COMMUNIQUÉS West-GlobeNewswire

UPDATE - Basecamp Research Appoints John Finn, Ph.D., as CSO, Expands Internationally with U.S. Lab and Offices, and Builds One of Europe's Largest Industrial Supercomputers with NVIDIA Accelerated Computing

06/01/2025 - 18:05

Finn, an industry leader in the field of cell and gene therapy, will lead company’s efforts to advance groundbreaking approaches to programmable genetic medicines Office and lab in Kendall Square (Cambridge, Mass.) to [...]

Preliminary Financial Figures for the 2024 Fiscal Year

06/01/2025 - 18:16

January 6, 2025 Announcement no. 01 Preliminary Financial Figures for the 2024 Fiscal Year COPENHAGEN, DENMARK, January 6, 2025, (GLOBE NEWSWIRE) – BioPorto A/S CVR-no. 17500317 (BioPorto or Company) (CPH:BIOPOR), an in [...]

UPDATE – LB Pharmaceuticals Announces Presentation at the 43rd Annual J.P. Morgan Healthcare Conference

06/01/2025 - 18:31

NEW YORK, Jan. 06, 2025 (GLOBE NEWSWIRE) -- LB Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing novel therapies for the treatment of neuropsychiatric diseases, including schizophrenia, today [...]

SAFE - Assemblée générale mixte du 30 décembre 2024

06/01/2025 - 19:00

Assemblée générale mixte du 30 décembre 2024 Fleurieux-sur-l’Arbresle - France - le 6 janvier 2025 à 19h . L’assemblée générale des actionnaires de Safe réunie le 30 décembre 2024 à Fleurieux-sur-l’Arbresle, sous la [...]

Bright Peak Therapeutics to Participate in 43rd Annual J.P. Morgan Healthcare Conference

06/01/2025 - 19:30

BASEL, Switzerland and SAN DIEGO, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Bright Peak Therapeutics, a clinical-stage biotechnology company focused on discovering and developing multifunctional immunotherapies for cancer, [...]

MESA LABS DECLARES QUARTERLY DIVIDEND

06/01/2025 - 21:00

LAKEWOOD, Colo., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0 [...]

AEON Biopharma, Inc. Announces Pricing of Approximately $20.0 Million Underwritten Public Offering

06/01/2025 - 15:00

IRVINE, Calif., Jan. 06, 2025 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (NYSE: AEON) (the “Company”), a clinical-stage biopharmaceutical company focused on developing a botulinum toxin complex under a 351(k) biosimilar [...]

Senti Bio Announces Additional $11.5 Million of Financing

06/01/2025 - 15:00

– Approximately $10 million additional investment in private placement equity financing – – $1.5 million from CIRM grant first announced in June 2024 – – Cash runway guidance extended into 2026 – SOUTH SAN FRANCISCO, [...]

Rendever Launches Alcove Sanctuary: A New VR Application Featuring an AI Family Companion

06/01/2025 - 15:00

VR app features Nova, the new embodied AI companion that sparks conversation and adventure from the comfort of the home BOSTON, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Rendever , the company leading the industry in immersive [...]

Editas Medicine to Present at the 43rd Annual J.P. Morgan Healthcare Conference

06/01/2025 - 15:00

CAMBRIDGE, Mass., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a leading gene editing company, today announced that the Company’s President and CEO Gilmore O’Neill, M.B., M.M.Sc., will present [...]

NeurAxis Inc. to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025

06/01/2025 - 15:00

CARMEL, Ind., Jan. 06, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and [...]

Predictive Oncology Announces Agreement to be Acquired by Renovaro

06/01/2025 - 15:10

- Combination creates immediate scientific synergies by harnessing complementary AI / ML platforms to improve patient outcomes across multiple cancer indications – - Deal terms align shareholders’ interest, augment [...]

Renovaro to Acquire Predictive Oncology in All-Stock Transaction

06/01/2025 - 15:15

Acquisition provides access to critical resources encompassing a biobank of more than 150,000 tumor specimens, 200,000 pathology slides and decades of longitudinal drug response data Data provides a critical pathway to [...]

Buckingham Psychiatry Unveils a New Way to Get Help via an Online Patient Portal

06/01/2025 - 15:50

Dr. Jacob Buinewicz, a Philadelphia-area general psychiatrist, added a patient portal to his new website in late 2024 DOYLESTOWN, Pa., Jan. 06, 2025 (GLOBE NEWSWIRE) -- As a general psychiatrist serving the Philadelphia [...]

Zealand Pharma to present at the 43rd Annual J.P. Morgan Healthcare Conference on January 13th

06/01/2025 - 17:00

Press Release – No. 1 / 2025 Zealand Pharma to present at the 43rd Annual J.P. Morgan Healthcare Conference on January 13th Copenhagen, Denmark, January 6, 2025 – Zealand Pharma A/S (CVR-no. 20045078), a biotechnology [...]

EUROAPI accueille le ministre de la Santé et de l’Accès aux soins Yannick Neuder et le ministre de l’Industrie et de ’Energie Marc Ferracci sur son site du Puy-de-Dôme

06/01/2025 - 17:40

Communiqué de presse La visite des unités de fabrication et de stockage de Vertolaye a permis de rappeler l’engagement de long terme d’EUROAPI en faveur de la souveraineté sanitaire Paris et Vertolaye – Le 6 janvier [...]

EUROAPI welcomes the French Minister for Health and Access to Healthcare Yannick Neuder and the French Minister for Industry and Energy Marc Ferracci to its Puy-de-Dôme site

06/01/2025 - 17:40

Press Release A tour of Vertolaye manufacturing and storage facilities highlighted EUROAPI’s long-term commitment to health sovereignty Paris and Vertolaye - January 6, 2025 – The French Minister for Health and Access [...]

Valneva rencontrera des investisseurs lors de la J.P. Morgan Healthcare Conference

06/01/2025 - 17:45

Saint Herblain (France), le 6 janvier 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), société spécialisée dans les vaccins, a annoncé aujourd’hui que des membres de son équipe dirigeante rencontreront des [...]

Valneva to Meet with Investors during the J.P. Morgan Healthcare Conference

06/01/2025 - 17:45

Saint Herblain (France), January 6, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announces that members of its management team will meet one-on-one with existing shareholders [...]